K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc76 participants52 sites · United States, Australia, CanadaCompletes Nov 2024
Phase 2Hepatocellular Carcinoma (HCC)Adjuvant Therapy in Patients with Hepatocellular Carcinoma (HCC) At High Risk of Recurrence After Curative Resection or Ablation
Postoperative adjuvant lenvatinibSupportive care measures
The First Affiliated Hospital with Nanjing Medical University276 participants1 site · ChinaCompletes Oct 2027